Flavonoid-rich diet slashes type 2 diabetes risk by up to 28%, new study reveals

No­vo Nordisk is an­oth­er step clos­er to launch­ing its once-week­ly in­sulin icodec now that the Eu­ro­pean Med­i­cines Agency’s Com­mit­tee for Med­i­c­i­nal Prod­ucts for Hu­man Use

Ad­dim­mune, a biotech that is work­ing on a cell ther­a­py for HIV, an­nounced Wednes­day that it plans to merge with 10X Cap­i­tal Ven­ture’s SPAC to be­come